Immunic Inc (NASDAQ: IMUX) Has Succeeded In Generating Interest In 2025, The Stock Is Down -3.93% Year-To-Date
Immunic Inc (NASDAQ:IMUX)’s traded shares stood at 0.42 million during the last session, with the company’s beta value hitting 1.95. At the close of trading,